Publications
Chosen filters:
Chosen filters:
Content analysis of Advance Directives completed by patients with advanced cancer as part of an Advance Care Planning intervention : insights gained from the ACTION trial Ghent University Vrije Universiteit Brussel
The dance without the dancer: writing dance in digital scores Ghent University
Healthcare use and healthcare costs for patients with advanced cancer : the international ACTION cluster-randomised trial on advance care planning Ghent University Vrije Universiteit Brussel
Background: Advance care planning supports patients to reflect on and discuss preferences for future treatment and care. Studies of the impact of advance care planning on healthcare use and healthcare costs are scarce. Aim: To determine the impact on healthcare use and costs of an advance care planning intervention across six European countries. Design: Cluster-randomised trial, registered as ISRCTN63110516, of advance care planning ...
Barriers to advance care planning in cancer, heart failure and dementia patients: A focus group study on general practitioners' views and experiences. Vrije Universiteit Brussel Ghent University KU Leuven
Background: The long-term and often lifelong relationship of general practitioners (GPs) with their patients is considered to make them the ideal initiators of advance care planning (ACP). However, in general the incidence of ACP discussions is low and ACP seems to occur more often for cancer patients than for those with dementia or heart failure.
Objective: To identify the barriers, from GPs' perspective, to initiating ACP and to gain ...
Objective: To identify the barriers, from GPs' perspective, to initiating ACP and to gain ...
Shaping Europe's first dance craze: Napoleon's 'Grande armée': a driving force behind the dissemination of dance repertoires in continental Europe - 1803 & 1815 Ghent University
During the first decade of the 19th century a remarkable pair of dances came into fashion in continental Europe: the walz and the quadrille. The pace at which this renouveau of dance fashion took shape, was unseen before. For several reasons the speed and geographical scope at which the introduction of the new dances materialized, leaves us struggling with many questions. The comparison with that other 19th century 'dancecraze' the polkamania, ...
Kalbeliya dance from Rajasthan : invented gypsy form or traditional snake charmers U+2019 folk dance? Ghent University
Advance care planning in patients with advanced cancer : a 6-country, cluster-randomised clinical trial Ghent University Vrije Universiteit Brussel
Background Advance care planning (ACP) supports individuals to define, discuss, and record goals and preferences for future medical treatment and care. Despite being internationally recommended, randomised clinical trials of ACP in patients with advanced cancer are scarce. Methods and findings To test the implementation of ACP in patients with advanced cancer, we conducted a cluster-randomised trial in 23 hospitals across Belgium, Denmark, ...
Advance care planning for adolescents with cancer and their parents Vrije Universiteit Brussel Ghent University
BACKGROUND: Research has highlighted the need for evidence-based interventions to improve paediatric advance care planning (pACP) in adolescents with cancer. Although adolescents express the desire and ability to share their values, beliefs and preferences for treatment, there is a lack of structured multicomponent interventions to improve parent-adolescent communication on different ACP themes including those not limited to end-of-life care. ...
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen Ghent University Vrije Universiteit Brussel Hasselt University KU Leuven
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop resistance that might be overcome with drug combinations. However, the number of possible combinations is vast, necessitating data-driven approaches to find optimal patient-specific treatments. Here we report AstraZeneca's large drug combination dataset, consisting of 11,576 experiments from 910 combinations across 85 molecularly characterized cancer cell ...